Poseida Therapeutics Inc (PSTX)
3.19
-0.16
(-4.63%)
USD |
NASDAQ |
May 17, 16:00
3.19
0.00 (0.00%)
After-Hours: 16:29
Poseida Therapeutics Total Assets (Quarterly): 262.58M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 262.58M |
| December 31, 2023 | 273.88M |
| September 30, 2023 | 302.25M |
| June 30, 2023 | 281.22M |
| March 31, 2023 | 313.62M |
| December 31, 2022 | 351.84M |
| September 30, 2022 | 380.48M |
| June 30, 2022 | 205.46M |
| March 31, 2022 | 248.15M |
| Date | Value |
|---|---|
| December 31, 2021 | 269.31M |
| September 30, 2021 | 261.94M |
| June 30, 2021 | 299.11M |
| March 31, 2021 | 333.34M |
| December 31, 2020 | 371.48M |
| September 30, 2020 | 405.17M |
| June 30, 2020 | 226.35M |
| March 31, 2020 | 156.30M |
| December 31, 2019 | 147.00M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
147.00M
Minimum
Dec 2019
405.17M
Maximum
Sep 2020
282.75M
Average
277.55M
Median
Total Assets (Quarterly) Benchmarks
| Biomea Fusion Inc | 168.49M |
| Cartesian Therapeutics Inc | 325.21M |
| Lantern Pharma Inc | 39.73M |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 13.55M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 177.99M |
| Shareholders Equity (Quarterly) | 84.59M |
| Debt to Equity Ratio | 0.6938 |
| Current Ratio | 2.557 |
| Net Debt Paydown Yield | -0.03% |